Sri Lanka’s Path to Smoke-Free Status: Science vs. Misinformation 📈

A recent medical analysis by Dr. R.S. Mowjood emphasizes the need for evidence-based regulation of reduced-risk alternatives to support Sri Lanka’s public health goals. Transitioning from combustible products to smokeless options is highlighted as a key strategy for tobacco harm reduction. • Core Scientific Findings The primary cause of smoking-related diseases is not nicotine itself, but the thousands of toxicants released during tobacco combustion. Public health bodies like the US FDA place products on a "continuum of risk," with tobacco-free nicotine pouches and vapour products at the lower end due to the absence of burning and tar. • International Benchmarks • Sweden: Daily smoking prevalence dropped to 5.4% (2024) via access to smokeless alternatives, resulting in the lowest lung cancer rates in the EU. • New Zealand: Daily smoking fell from 14.5% to 6.8% (2016–2023) by integrating vapour products into national cessation policies. • Product Differentiation It is critical to distinguish between modern nicotine pouches (food-grade ingredients, zero tobacco) and traditional Sri Lankan oral products like chewing tobacco, paan, and gutka, which contain betel nut and lime, carrying significantly higher toxicant levels. • Strategic Outlook To achieve a "Smoke-Free Sri Lanka," policymakers must adopt pragmatic, science-led regulations. This involves separating facts from myths to provide adult smokers with quality-controlled, reduced-risk alternatives that significantly lower exposure to harmful chemicals compared to traditional cigarettes.